1. Malaysia Stocks

  2. •

    Producer manufacturing

  3. •

    Miscellaneous manufacturing
Hartalega Holdings Bhd.

Hartalega Holdings Bhd.

1.15
MYR
+0.09
(+8.49%)
21.04P/E
Nov 10Next Earn
Hartalega Holdings Bhd.
MYX:HARTA
(Bursa Malaysia)

Recent

price

1.15

P/E

ratio

21.04

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
MYR
0.25
0.27
0.35
0.37
0.37
0.46
0.55
0.73
0.85
0.87
1.96
2.31
0.71
0.54
0.76
0.63
0.64
Revenue per Share
0.07
0.06
0.08
0.08
0.07
0.08
0.09
0.13
0.14
0.13
0.84
0.95
-0.07
- -
0.02
0.03
0.05
Basic EPS, GAAP
0.06
0.04
0.04
0.02
-0.07
-0.06
0.03
0.04
0.06
0.12
0.8
0.84
-0.1
-0.07
-0.02
0.06
0.05
Free Cash Flow per Basic Share
0.02
0.02
0.03
0.04
0.03
0.04
0.04
0.06
0.09
0.07
0.18
0.87
0.07
- -
0.12
- -
0.02
Dividend per Share
0.17
0.21
0.26
0.32
0.4
0.46
0.51
0.6
0.67
0.75
1.45
1.5
1.36
1.36
1.27
1.3
1.3
Book Value per Share
0.17
0.21
0.26
0.31
0.39
0.45
0.51
0.6
0.67
0.74
1.44
1.49
1.35
1.35
1.26
1.29
1.29
Tangible Book Value per Share
2,908
3,497
2,928
2,967
3,112
3,280
3,283
3,306
3,325
3,366
3,417
3,418
3,417
3,415
3,413
3,407
3,410
Basic Weighted Avg Shares
735
931
1,032
1,107
1,146
1,498
1,822
2,406
2,827
2,924
6,703
7,888
2,410
1,838
2,586
2,135
2,188
Sales/Revenue/Turnover
33.38
27.94
29.55
27.93
24.17
21.17
19.21
22.21
19.86
19.36
56.98
58.84
-8.58
2.51
1.93
5.49
8.84
Operating Margin (%)
25
29
32
45
46
71
71
88
104
125
138
152
163
132
151
164
165
Depreciation Expense
190
201
233
233
210
257
283
439
455
434
2,886
3,234
-235
13
75
103
160
Net Income, GAAP
21.62
22.05
23.19
24.49
24.08
18.66
18.82
16.49
17.41
21.79
23.85
30.08
- -
48.56
- -
12.91
17.32
Effective Tax Rate (%)
25.89
21.63
22.61
21.03
18.3
17.18
15.53
18.25
16.1
14.83
43.04
41
-9.76
0.68
2.88
4.82
7.33
Profit Margin (%)
207
292
275
310
261
348
329
453
486
681
2,998
2,381
2,006
1,895
1,484
1,624
1,671
Working Capital
24
12
5
2
- -
206
163
122
195
191
252
140
64
7
1
9
8
LT Debt
495
620
765
944
1,271
1,504
1,685
1,997
2,259
2,543
4,999
5,145
4,658
4,644
4,319
4,417
4,424
Total Equity
40.58
33.88
32.36
26.66
18.71
16.98
15.14
20.68
18.85
16.3
69.83
57.83
- -
0.5
- -
2.33
3.64
Return on Invested Capital (%)
41.35
34.4
32.89
26.96
18.81
16.99
15.13
20.65
18.88
16.27
70.33
60.18
- -
0.19
- -
2.39
3.68
Return on Capital (%)
44.85
36.16
33.74
27.29
18.97
18.58
17.78
23.88
21.42
18.08
76.8
64.07
-4.82
0.27
1.66
2.36
3.66
Return on Common Equity (%)

Capital Structure

MYR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
2
1
2
LT Borrowings
7
8
7
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3,407
3,407
3,407
Market Capitalization
3,373
3,919
3,373

Working Capital

MYR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
1,808
1,913
1,957
Cash, Cash Equivalents & STI
1,059
1,144
1,127
Accounts Receivable, Net
295
274
234
Inventories
296
327
465
Total Current Liabilities
225
289
286
Payables & Accruals
- -
- -
- -
ST Debt
2
1
2
Deferred Revenue
- -
- -
- -

Growth Rates

MYR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
14.12%
-2.32%
2.26%
Free Cash Flow
6.28%
-110.26%
-345.63%
Net Income, GAAP
96.34%
66.8%
38.2%
Sales/Revenue/Turnover
15.16%
-10.45%
-17.41%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

MYR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
584
652
738
612
2,586
2026
553
540
527
515
2,135
2027
606
- -
- -
- -
- -

Quarterly Earnings Per Share

MYR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.01
- -
0.01
- -
0.02
2026
- -
0.01
0.01
0.01
0.03
2027
0.02
- -
- -
- -
- -

Quarterly Dividends Per Share

MYR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
0.12
2026
- -
- -
- -
- -
- -
2027
0.02
- -
- -
- -
- -
Similar Companies
Astral Limited (NSE:ASTRAL)
Supreme Industries Limited (NSE:SUPREMEIND)
V.S. Industry Bhd. (MYX:VS)
Izmir Firca Sanayi ve Ticaret AS (BIST:IZFAS)
Kuzey Boru A.S. (BIST:KBORU)
Isik Plastik Sanayi VE Dis Ticaret Pazarlama AS (BIST:ISKPL)
Business
Hartalega Holdings Berhad Hartalega Holdings Berhad (5168.KL), an investment holding company founded in 1988 and headquartered in Kuala Lumpur, Malaysia, manufactures, retails and wholesales nitrile, latex, polychloroprene and polyisoprene gloves through subsidiaries including Hartalega Sdn Bhd, Hartalega NGC Sdn Bhd and Hartalega Research Sdn Bhd; the company offers core products such as standard nitrile examination gloves (3.2g), high-stress-relaxation nitrile surgical gloves, COATS® colloidal oatmeal coated gloves, BDG™ biodegradable gloves, AMG™ antimicrobial gloves, powder-free latex examination gloves and Goodpac™ smart packing systems for single-glove dispensing, serving healthcare, dental, food, industrial, veterinary, tattoo, life sciences, spa, beauty salon, laboratory, semiconductor, consumer electronics, automotive maintenance and spray painting markets. Hartalega Holdings Berhad exports to over 70 countries across five continents via its MUN Global distribution arm, with key geographic segments in North America (57% of sales), Europe (21%), Asia, Australia, Malaysia, South America and the Middle East; it operates eight advanced plants at the Next Generation Complex (NGC) in Sepang, featuring 92 production lines with an installed capacity of 37 billion pieces annually, two cogeneration power plants generating up to 65 MW, robotic stripping systems, AI vision systems and a digital manufacturing control room. The company pursues innovation through R&D in automation, sustainability and product diversification, holding certifications including ISO 9001:2015, ISO 13485:2016, ISO 14001:2015, ISO 45001:2018 and FDA 510(k), while employing 7,559 staff and maintaining a net cash position of RM919 million. In FY2025 (ended March 31, 2025), Hartalega Holdings Berhad achieved revenue of RM2.6 billion (up 41% year-over-year), operating profit of RM53 million, profit after tax of RM74 million and capacity utilization of 80% at NGC following the Bestari Jaya facility decommissioning; it commissioned Plant 8 at the NGC 1.5 expansion, invested RM193 million in capex for automation and digitalization including AI integration, completed its first critically reviewed life cycle assessments for three products under ISO 14040/14044, and completed its inaugural strategic acquisition of a 70% stake in Medico Sdn Bhd (RM7 million) to diversify into healthcare product distribution, complementing MUN Global's portfolio and expanding into government hospitals.